EUVIMEDEUVIMED entdecken
Open Access

NCI SEER-Linked Virtual Tissue Repository Pilot

Pamela Sanchez, Alison L Van Dyke iD, Valentina I Petkov, Yao Yuan, Sarah Bonds, Connor Valenzuela, Alyssa W Tuan, Radim Moravec, Sean F Altekruse, Aatur D Singhi, Kate M Serdy, Yun Wu und 9 weitere

JNCI Monographs · 2024

DOI: 10.1093/jncimonographs/lgae034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JNCI Monographs, 2024. Verfasst von Pamela Sanchez und 20 weiteren Autor:innen. Beteiligte Einrichtung: Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD, USA. Hauptthemen laut MEDLINE: SEER Program, Carcinoma, Pancreatic Ductal, Breast Neoplasms, Pancreatic Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Institutes of Healt, NCI NIH HHS, Public Health Institute, Cancer Registry of Greater California.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The Surveillance, Epidemiology, and End Results (SEER) Program with the National Cancer Institute tested whether population-based cancer registries can serve as honest brokers to acquire tissue and data in the SEER-Linked Virtual Tissue Repository (VTR) Pilot.

Methods

We collected formalin-fixed, paraffin-embedded tissue and clinical data from patients with pancreatic ductal adenocarcinoma (PDAC) and breast cancer (BC) for two studies comparing cancer cases with highly unusual survival (≥5 years for PDAC and ≤30 months for BC) to pair-matched controls with usual survival (≤2 years for PDAC and ≥5 years for BC). Success was defined as the ability for registries to acquire tissue and data on cancer cases with highly unusual outcomes.

Results

Of 98 PDAC and 103 BC matched cases eligible for tissue collection, sources of attrition for tissue collection were tissue being unavailable, control paired with failed case, second control that was not requested, tumor necrosis ≥20%, and low tumor cellularity. In total, tissue meeting the study criteria was obtained for 70 (71%) PDAC and 74 (72%) BC matched cases. For patients with tissue received, clinical data completeness ranged from 59% for CA-19-9 after treatment to >95% for margin status, whether radiation therapy and chemotherapy were administered, and comorbidities.

Conclusions

The VTR Pilot demonstrated the feasibility of using SEER cancer registries as honest brokers to provide tissue and clinical data for secondary use in research. Studies using this program should oversample by 45% to 50% to obtain sufficient sample size and targeted population representation and involve subspecialty matter expert pathologists for tissue selection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SEER ProgramCarcinoma, Pancreatic DuctalBreast NeoplasmsPancreatic NeoplasmsHumansFemalePilot ProjectsUnited StatesMaleMiddle AgedAgedNational Cancer Institute (U.S.)Tissue BanksRegistriesAdultCase-Control Studies

Autor:innen und Institutionen

  • Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD, USA.
  • Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
  • Department of Pathology, Allegheny Health Network, Pittsburgh, PA, USA.
  • Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Public Health Institute, Cancer Registry of Greater California, Sacramento, CA, USA.
  • The Utah Cancer Registry, Salt Lake City, UT, USA.

ORCID-Profile: Alison L Van Dyke, Xiao-Cheng Wu, Lynn Matrisian

Förderung

  • National Institutes of Healt
  • NCI NIH HHS
  • Public Health Institute, Cancer Registry of Greater California
  • School of Public Health Louisiana State University Health New Orleans
  • University of Hawaii Cancer Center
  • NIH HHS
  • Surveillance Research Program, Division of Cancer Control and Population Sciences
  • HHS

Zitieren

APA

Sanchez, P., Van Dyke, A. L., Petkov, V. I., Yuan, Y., Bonds, S., Valenzuela, C., Tuan, A. W., Moravec, R., Altekruse, S. F., Singhi, A. D., Serdy, K. M., Wu, Y., Cress, R. D., Doherty, J. A., Mueller, L., Hernandez, B. Y., Lynch, C. F., Tucker, T. C., Wu, X. C., …, & Penberthy, L. (2024). NCI SEER-Linked Virtual Tissue Repository Pilot. JNCI Monographs. https://doi.org/10.1093/jncimonographs/lgae034

Vancouver

Sanchez P, Van Dyke AL, Petkov VI, Yuan Y, Bonds S, Valenzuela C, et al. NCI SEER-Linked Virtual Tissue Repository Pilot. JNCI Monographs. 2024. doi:10.1093/jncimonographs/lgae034

BibTeX
@article{Sanchez2024,
  author = {Sanchez, Pamela and Van Dyke, Alison L and Petkov, Valentina I and Yuan, Yao and Bonds, Sarah and Valenzuela, Connor and Tuan, Alyssa W and Moravec, Radim and Altekruse, Sean F and Singhi, Aatur D and Serdy, Kate M and Wu, Yun and Cress, Rosemary D and Doherty, Jennifer A and Mueller, Lloyd and Hernandez, Brenda Y and Lynch, Charles F and Tucker, Thomas C and Wu, Xiao-Cheng and Matrisian, Lynn and Penberthy, Lynne},
  title = {NCI SEER-Linked Virtual Tissue Repository Pilot},
  journal = {JNCI Monographs},
  year = {2024},
  doi = {10.1093/jncimonographs/lgae034}
}
Kostenlos starten →